Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 5/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.42 |
| ▸ | REN | P00797 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7297651 | 0.92 | ITGB3 (0.47) | ACEITGB3ITGA2BRENOPRM1 | |
| SCHEMBL7303956 | 0.84 | CPT2 (0.42) | ACEF2 | |
| SCHEMBL7304579 | 0.83 | SPHK2 (0.43) | ACEF2DPP4DPP8 | |
| SCHEMBL7302617 | 0.76 | ACE (0.45) | ACEF2 | |
| SCHEMBL7297128 | 0.75 | CPT2 (0.44) | ACEDPP4DPP8 | |
| SCHEMBL11096587 | 0.75 | ACE (0.54) | ACEITGB3ITGA2BRENACE2 | |
| SCHEMBL11097636 | 0.74 | ACE (0.55) | ACEITGB3ITGA2BRENACE2 | |
| SCHEMBL11094200 | 0.74 | ACE (0.52) | ACEITGB3ITGA2BRENDPP4 | |
| SCHEMBL7302798 | 0.74 | SPHK2 (0.44) | ACEOPRM1OPRD1DPP4DPP8 | |
| SCHEMBL13533686 | 0.73 | ACE (0.65) | ACEITGB3ITGA2BRENOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0526877-A2 | Peptide aldehydes as antithrombotic agents | Bristol-Myers Squibb Company (US) | 1993-02-10 | — | — | EP | disclosed |